A fungal infection long considered routine has quietly crossed into new territory: drug-resistant ringworm, unresponsive to the medications that once reliably cleared it, has now been documented in 29 countries. What was once a minor inconvenience for patients has become a window into the larger story of antimicrobial resistance — the way organisms evolve under pressure, outpacing the tools we build to contain them. The spread asks an old question in a new form: how quickly can human systems of care adapt when the ground beneath them shifts?
Drug-resistant ringworm fungus spreads across 29 countries
Patients infected with drug-resistant ringworm face limited treatment options and prolonged infection complications.